yao xue jin zhan

..............page:717

ju jiao fu ke xiang guan ji bing de lin chuang yong yao
wu qiang ;

..............page:721

Prospect in PARP-1 Inhibitors as Targeted Therapeutics for Epithelial Ovarian Cancer
CHEN Xiaoxiang;LIU Qi;Department of Gynecologic Oncology;Jiangsu Cancer Hospital;Cancer Hospital Affiliated to Nanjing Medical University;Department of Gynecology;Nanjing General Hospital of Nanjing Military Command;PLA;

..............page:722-728

yao xue jin zhan za zhi 2015 nian zheng ding qi shi

..............page:728

Present Status of Research on Application of Recombinant Human Erythropoietin in the Treatment of Perioperative Gynecological Anemia
LI Juan;CHEN Zhiqian;WU Qiang;Department of Gynecological Oncology;Jiangsu Cancer Hospital;Cancer Hospital Affiliated to Nanjing Medical University;Shenyang Sunshine Pharmaceutical CO.;LTD.;

..............page:729-732

Latest Progress in Research and Development of New Anti-Rheumatoid Arthritis Drugs
DU Haizhou;Medical Library of the Chinese PLA;

..............page:733-740

Research Progress and Market Trend of the Fifth Generation Cephalosporin Antibiotics
LI Jieyun;GU Juefen;Ocean University of China;School of Life Science and Technology;China Pharmaceutical University;

..............page:741-746

Research Status of Enediyne Antitumor Antibiotics and Their Targeted Drugs
YANG Zhenzheng;XING Aimin;ZHENG Xiaonan;GU Juefen;Editorial Office of Progress in Pharmaceutical Sciences;China Pharmaceutical University;School of Life Science and Technology;China Pharmaceutical University;

..............page:747-753

Study on Injectable Thermosensitive In-situ Hydrogel as Ganciclovir Delivery System
WANG Qiyue;SHEN Yan;TU Jiasheng;Department of Pharamaceutics;School of Pharmacy;China Pharmaceutical University;

..............page:754-760

Determination of Residual Organic Solvents in Imatinib Mesylate by Capillary GC
YAN Zhengyu;LIU Xinying;WANG Rui;LIAO Shenghua;School of Science;China Pharmaceutical University;

..............page:761-764

yao xue jin zhan zai guo nei 66 zhong yao xue lei qi kan zhong pian jun xia zai liang pai ming di 1 wei
ben kan bian ji bu ;

..............page:764

Top 5 of the Most Promising New Drugs Entering Phase Ⅰ-Ⅲ Trials and Receiving Approval or Launched in the World——The First Quarter of 2014
Thomson Reuters;

..............page:765-772

Developments in Clinical Trials:Clinical Data and Laboratory Practice
Thomson Reuters;

..............page:773-782

Spotlight on Drugs of Chronic Obstructive Pulmonary Disease
Thomson Reuters;

..............page:783-792

Analysis Report of the Global Psychiatric Disorder Therapeutic Drug Development(2014)(Ⅱ)
WANG Chunli;MAO Yanyan;LI Ziyan;WU Hui;GAO Liubin;Shanghai Institute of Materia Medica Information Center;Chinese Academy of Science;

..............page:793-800